Yutani, Shigeru <br/><br/>
Feasibility study of personalized peptide vaccination for hepatocellular carcinoma patients refractory to locoregional therapies.  [electronic resource] 

 -  Cancer science  Sep 2017 
 - 1732-1738 p.  digital 
<br/><br/> Publication Type: Clinical Trial, Phase II; Journal Article 
<br/><br/><label>ISSN: </label>1349-7006 
<br/><br/><label>Standard No.: </label>10.1111/cas.13301  doi 
<br/><br/><label>Subjects--Topical Terms: </label><br/>Adult<br/>Aged<br/>Aged, 80 and over<br/>Antineoplastic Agents--administration & dosage<br/>Cancer Vaccines--administration & dosage<br/>Carcinoma, Hepatocellular--mortality<br/>Chemoembolization, Therapeutic<br/>Combined Modality Therapy<br/>Drug Resistance, Neoplasm<br/>Feasibility Studies<br/>Female<br/>Humans<br/>Kaplan-Meier Estimate<br/>Liver Neoplasms--mortality<br/>Male<br/>Middle Aged<br/>Niacinamide--administration & dosage<br/>Phenylurea Compounds--administration & dosage<br/>Precision Medicine<br/>Sorafenib<br/>T-Lymphocytes, Cytotoxic--physiology<br/>Treatment Outcome<br/>Vaccination<br/>Vaccines, Subunit--administration & dosage